ATYR
aTyr Pharma, Inc.
0.2783$
-1.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 0.03 | 0.05 | 0.04 | 1.17 | 0.02 | 0.02 | 0.19 | – | – | – | – | – | – | – | 0.36 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.53 | – | – | – | – | – | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.15 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.03 | 0.05 | 0.04 | 1.17 | 0.02 | 0.02 | 0.19 | – | – | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | 0.33 | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 | -0.15 | 0.00 | 0.00 | -0.23 | 0.00 | 0.00 | – | – | |
| 6.14 | 5.40 | 5.43 | 4.95 | 3.87 | 2.50 | 2.89 | 3.04 | 1.97 | 1.64 | 1.38 | 1.02 | 0.99 | 0.92 | 0.53 | 0.47 | 0.48 | 0.44 | 0.32 | 0.47 | 0.28 | 0.21 | 0.32 | 0.33 | 0.34 | 0.51 | 0.22 | 0.18 | 0.18 | 0.22 | 0.20 | 0.19 | 0.20 | 0.15 | 0.14 | 0.17 | 0.23 | 0.11 | 0.07 | 0.07 | 0.48 | |
| 2.05 | 2.00 | 2.36 | 2.05 | 2.00 | 2.77 | 1.91 | 1.63 | 1.16 | 1.11 | 1.05 | 0.75 | 0.49 | 0.65 | 0.38 | 0.23 | 0.21 | 0.22 | 0.19 | 0.17 | 0.14 | 0.10 | 0.13 | 0.12 | 0.13 | 0.12 | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.17 | |
| 8.19 | 7.39 | 7.79 | 7.00 | 5.87 | 5.27 | 4.80 | 4.67 | 3.13 | 2.75 | 2.43 | 1.77 | 1.48 | 1.57 | 0.90 | 0.70 | 0.69 | 0.66 | 0.51 | 0.65 | 0.43 | 0.31 | 0.44 | 0.45 | 0.46 | 0.61 | 0.29 | 0.24 | 0.21 | 0.26 | 0.26 | 0.24 | 0.24 | 0.04 | 0.18 | 0.23 | 0.05 | 0.15 | 0.11 | 0.11 | 0.42 | |
| -8.19 | -7.39 | -7.79 | -7.00 | -5.87 | -5.27 | -4.80 | -4.67 | -3.13 | -2.75 | -2.43 | -1.74 | -1.43 | -1.53 | 0.27 | -0.68 | -0.67 | -0.47 | -0.51 | -0.65 | -0.43 | -0.31 | -0.44 | -0.45 | -0.47 | -0.27 | -0.31 | -0.25 | -0.22 | -0.27 | -0.25 | -0.24 | -0.24 | -0.19 | -0.18 | -0.23 | -0.28 | -0.15 | -0.12 | -0.11 | -0.65 | |
| -8.16 | -7.45 | -7.91 | -7.14 | -6.07 | -5.40 | -5.01 | -4.88 | -3.33 | -2.92 | -2.54 | -1.80 | -1.47 | -1.58 | 0.25 | -0.69 | -0.68 | -0.47 | -0.51 | -0.64 | -0.42 | -0.31 | -0.44 | -0.44 | -0.46 | -0.26 | -0.29 | -0.22 | -0.20 | -0.25 | -0.23 | -0.23 | -0.23 | -0.18 | -0.17 | -0.22 | -0.27 | -0.14 | -0.11 | -0.11 | -0.62 | |
| – | -0.03 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | |
| -8.16 | -7.42 | -7.91 | -7.14 | -6.07 | -5.40 | -5.01 | -4.88 | -3.33 | -2.92 | -2.54 | -1.80 | -1.47 | -1.54 | 0.25 | -0.69 | -0.68 | -0.47 | -0.51 | -0.64 | -0.42 | -0.31 | -0.44 | -0.44 | -0.46 | -0.26 | -0.29 | -0.22 | -0.20 | -0.25 | -0.23 | -0.23 | -0.23 | -0.18 | -0.17 | -0.22 | -0.26 | -0.14 | -0.11 | -0.11 | -0.62 | |
| -8.06 | -7.26 | -7.66 | -6.90 | -5.79 | -5.19 | -4.72 | -4.58 | -3.04 | -2.67 | -2.29 | -1.63 | -1.34 | -1.44 | 0.32 | -0.64 | -0.64 | -0.44 | -0.49 | -0.62 | -0.40 | -0.30 | -0.43 | -0.43 | -0.45 | -0.23 | -0.27 | -0.21 | -0.18 | -0.24 | -0.22 | -0.22 | -0.22 | -0.18 | -0.17 | -0.21 | -0.26 | -0.14 | -0.11 | -0.09 | -0.60 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.